Fragment Optimization
Fragment Optimization is a methodological process in drug discovery that involves the systematic enhancement of weak-binding molecular fragments into potent lead compounds through iterative structural modification and affinity improvement.
185
Publications
12.3K
Citations
1.4K
Authors
304
Institutions
Publications per year
2017–2026
70
185
Two‐ and Three‐dimensional Rings in Drugs
Matteo Aldeghi, Shipra Malhotra, David L. Selwood et al. · Chemical Biology & Drug Design · 2013 · 362 citations · Full text
Andrew Woodhead, Hayley C. Angove, Maria G. Carr et al. · Journal of Medicinal Chemistry · 2010 · 263 citations
1–5 of 185
1.4K
6
h-index
5
h-index
5
h-index
5
h-index
5
h-index
1–5 of 1.4K
304
University of Cambridge
Cambridge, United Kingdom
7 h-index
39 publications
2.6K citations
Novartis (Switzerland)
Basel, Switzerland
6 h-index
27 publications
1.3K citations
AstraZeneca (Sweden)
Södertälje, Sweden
6 h-index
23 publications
1.5K citations

Vrije Universiteit Amsterdam
Amsterdam, The Netherlands
5 h-index
18 publications
1.8K citations

University of Groningen
Groningen, The Netherlands
5 h-index
22 publications
1.2K citations

Centre National de la Recherche Scientifique
Paris, France
4 h-index
33 publications
8.4K citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
4 h-index
59 publications
8.7K citations
Novartis Institutes for BioMedical Research
Basel, Switzerland
4 h-index
20 publications
602 citations
1–8 of 304
51 publications · 4.1K citations
35
h-index
11 publications · 305 citations
11
h-index
10 publications · 290 citations
10
h-index
8 publications · 252 citations
8
h-index
7 publications · 235 citations
7
h-index
1–5